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Abstract 
Background: Candidate‑gene studies on fibromyalgia susceptibility often include a small number of single nucleo‑
tide polymorphisms (SNPs), which is a limitation. Moreover, there is a paucity of evidence in Europe. Therefore, we 
compared genotype frequencies of candidate SNPs in a well‑characterised sample of Spanish women with fibromyal‑
gia and healthy non‑fibromyalgia women.
Methods: A total of 314 women with a diagnosis of fibromyalgia (cases) and 112 non‑fibromyalgia healthy (con‑
trols) women participated in this candidate‑gene study. Buccal swabs were collected for DNA extraction. Using 
TaqMan™ OpenArray™, we analysed 61 SNPs of 33 genes related to fibromyalgia susceptibility, symptoms, or potential 
mechanisms.
Results: We observed that the rs841 and rs1799971 GG genotype was more frequently observed in fibromyalgia 
than in controls (p = 0.04 and p = 0.02, respectively). The rs2097903 AT/TT genotypes were also more often present in 
the fibromyalgia participants than in their control peers (p = 0.04). There were no differences for the remaining SNPs.
Conclusions: We identified, for the first time, associations of the rs841 (guanosine triphosphate cyclohydrolase 1 
gene) and rs2097903 (catechol‑O‑methyltransferase gene) SNPs with higher risk of fibromyalgia susceptibility. We 
also confirmed that the rs1799971 SNP (opioid receptor μ1 gene) might confer genetic risk of fibromyalgia. We did 
not adjust for multiple comparisons, which would be too stringent and yield to non‑significant differences in the 
genotype frequencies between cases and controls. Our findings may be biologically meaningful and informative, and 
should be further investigated in other populations. Of particular interest is to replicate the present study in a larger 
independent sample to confirm or refute our findings. On the other hand, by including 61 SNPs of 33 candidate‑
genes with a strong rationale (they were previously investigated in relation to fibromyalgia susceptibility, symptoms 
or potential mechanisms), the present research is the most comprehensive candidate‑gene study on fibromyalgia 
susceptibility to date.
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Background
Fibromyalgia is a disease in which people experi-
ence chronic diffuse musculoskeletal pain that is usu-
ally accompanied by other symptoms such as fatigue, 
unrefreshed sleep, and cognitive problems [1–4]. This 
disease is nine times more common in women than in 
men [5]. Family aggregation suggests but not confirm 
genetic susceptibility to fibromyalgia [6]. Variations in 
neurotransmitter-related genes increase susceptibility 
to fibromyalgia via hypersensitivity to peripheral pain-
ful stimulus by the central nervous system (CNS) [7]. 
Catechol-O-methyltransferase (COMT), the most widely 
studied gene in fibromyalgia, is involved in degrading 
catecholamines and several other neurotransmitters and, 
therefore, in modulating pain perception by the CNS. 
The association between COMT single nucleotide poly-
morphisms (SNPs) and fibromyalgia susceptibility is con-
troversial [7, 8].
Guanosine triphosphate cyclohydrolase 1 (GCH1) and 
opioid receptor μ1 (OPRM1) are candidate neurotrans-
mitter-related genes that may confer fibromyalgia suscep-
tibility [9, 10]. GCH1 gene participates in the synthesis of 
dopamine and serotonin. In Korean individuals, the rs841 
SNP was associated with discomfort with a tender point 
examination [9]. OPRM1 gene encodes μ-opioid receptor 
that bids opiates. In the Turkish population, a study iden-
tified that rs1799971 SNP is associated with fibromyalgia 
susceptibility [10]. However, whether GCH1 and OPRM1 
genes are associated with fibromyalgia susceptibility in 
the Caucasian population is unknown.
Candidate-gene studies on fibromyalgia susceptibil-
ity often include a small number of SNPs (e.g., [9–11]), 
which is a limitation [12, 13]. Additionally, there is a pau-
city of evidence in Europe. The present candidate-gene 
study compared genotype frequencies of candidate SNPs 
in a well-characterised sample of Spanish women with 
fibromyalgia (cases) vs. healthy non-fibromyalgia women 
(controls). We, therefore, analysed SNPs that had been 
previously investigated in relation to fibromyalgia sus-
ceptibility, symptoms, or potential mechanisms.
Methods
Participants
The participants were recruited mainly via fibromyalgia 
associations from Andalusia (southern Spain). The fibro-
myalgia patients invited to non-fibromyalgia acquaint-
ances with similar sociodemographic characteristics 
to participate in the study as controls. All participants 
signed an informed consent form. The Ethics Commit-
tee of the Virgen de las Nieves Hospital (Granada, Spain) 
approved the study. We followed the ethical guidelines of 
the Declaration of Helsinki.
The fibromyalgia participants had been previously 
diagnosed with fibromyalgia by a professional rheuma-
tologist and met the 1990 American College of Rheu-
matology (ACR) criteria for fibromyalgia, which was 
further confirmed by a tender point examination [1]. 
Controls neither had a medical diagnosis of fibromyal-
gia nor fulfilled the 1990 ACR criteria.
Genetic analysis
The participants were genotyped for 61 SNPs (online 
Additional file  1: Table  S1) that had been previously 
investigated in relation to fibromyalgia susceptibil-
ity, symptoms, or potential mechanisms (online Addi-
tional file 1: Table S2). As described elsewhere [14, 15], 
we collected buccal mucosa cells and we performed 
DNA non-organic extraction (proteinase K and salt-
ing-out) procedures. Afterwards, we conducted a 
spectrophotometric quantification (NanoDrop 2000c, 
ThermoFisher). All the samples were standardised to 
50 ng/μL and they had an A260/230 ratio between 1.7 
and 1.9. The samples in low concentration values were 
processed by Genomiphi™ V2 DNA Amplification Kit 
(Sigma Aldrich). Until being processed, all the sam-
ples were stored at −  20  °C. The  OpenArray® geno-
typing was performed according to the manufacturer’s 
protocol using Accufill™ system liquid robot that adds 
1.2 μl of genomic DNA sample and 3.8 µl of the follow-
ing reagents: 2×  TaqMan® Universal PCR Master Mix, 
No  AmpErase® UNG, 20× Primer and  TaqMan® Probe 
(FAM™ dye) mix, and sterile-filtered water. The online 
Additional file  1: Table  S3 shows the manufacturer 
thermal cycling conditions.
Plates include a NTC for each SNP in the analysis, 
and each plate has a total of 48 samples. Online Addi-
tional file  1: Tables S1 and S4 provide further details 
about the  TaqMan®  OpenArray® custom assay designs 
and the 61 analysed SNPs, respectively. We performed 
a TaqMan™ OpenArray™ Genotyping Plate, Custom 
Format 64 QuantStudio™ 12  K Flex. The data were 
analysed using the  TaqMan® Genotyper Software and 
downstream analysis using the AutoCaller™ Software.
Statistical analysis
The Hardy-Weinberg equilibrium (HWE) and link-
age disequilibrium (LD = r2 > 0.5) were checked for all 
the SNPs using SNPStats v3.0.1 [16]. Using SPSS for 
Mac v.20.0 (IBM, Armonk, NY, USA), we computed 
Pearson’s χ2 and logistic regression to analyse the dif-
ferences between fibromyalgia and controls on SNPs 
genotype frequency. Significance was set at p < 0.05.
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Results
Online Additional file  1: Table  S5 shows the character-
istics of the participants included in the present study. 
Those SNPs that did not fulfil genotyping quality controls 
were excluded. Through this strict filtering out rule we 
excluded the following nine SNPs because they did not 
meet the HWE criterion: the rs6323, rs7911, rs136078, 
rs806377, rs1050450, rs3746544, rs4411417, rs7124442, 
and rs12620053. HWE and LD were confirmed for the 
remaining 52 SNPs, which were, therefore, included in 
the present study.
The rs841and rs1799971 GG genotypes were more fre-
quently observed in fibromyalgia than in controls [odds 
ratio (OR) (95% confidence interval, 95% CI)  =  1.66 
(1.03–2.67), p  =  0.04 and 1.72 (1.11–2.67), p  =  0.02, 
respectively; Table  1]. The rs2097903 AT/TT genotypes 
were also present in the fibromyalgia participants more 
often than in their non-fibromyalgia peers [OR (95% 
CI) = 1.66 (1.02–2.71), p = 0.04; Table 1). There were no 
differences for the remaining 49 SNPs (online Additional 
file 1: Table S6).
Discussion
The present candidate-gene study (including 61 SNPs of 
33 genes) is the largest conducted on fibromyalgia sus-
ceptibility. We identified, for the first time, that the rs841 
(GCH1 gene) and rs2097903 (COMT gene) SNPs were 
associated with having fibromyalgia. We also confirmed 
that the rs1799971 SNP (OPRM1 gene) seems to confer 
genetic risk of fibromyalgia. The COMT gene is involved 
in neurotransmitters degradation while the GCH1 gene 
is related to their synthesis. The μ-opioid receptor, which 
is encoded by the OPRM1 gene, bids both endogenous 
and exogenous opiates. In line with previous literature 
[7], our findings suggest that an augmented processing 
of pain may be involved in the genetic susceptibility to 
fibromyalgia.
Vargas-Alarcón et  al. [8] showed that genotype fre-
quencies of the rs4680, rs4818, and rs6269 SNPs, but 
not rs2097903, were different between fibromyalgia 
and control participants. In contrast, we found that the 
rs2097903 SNP was different between the study cohorts; 
78.8% of the patients, and only 69.1% of the controls were 
TT genotype carriers. Vargas-Alarcón et al. [8] excluded 
fibromyalgia participants with rheumatic comorbidi-
ties and control participants with chronic pain. Of note 
is that we corroborated the rheumatologist diagnosis of 
our fibromyalgia participants by fulfilling the 1990 ACR 
criteria and discarding it in controls. We included fibro-
myalgia participants with other rheumatic conditions 
and controls that experienced chronic pain if they did not 
fulfil the fibromyalgia diagnosis. Therefore, the ecological 
validity of our findings is high. Moreover, a later genome-
wide association study [7] in the Spanish population also 
failed to replicate the findings by Vargas-Alarcón et  al. 
[8].
GCH enzyme participates in nitric oxide (NO) pro-
duction. It is widely recognised that NO plays a key role 
in health and disease by a substantial number of paths 
[17]. Among other roles, increased NO concentrations 
often lead to dorsal horn hyperexcitability [18]. Over-
all, our results are consistent with a previous study in 
a Korean population in which genotype frequencies 
of rs841, rs752688, rs4411417, and rs3783641 SNPs in 
Table 1 Genotype frequencies of  single nucleotide polymorphisms (SNP) in  fibromyalgia (FM) and  non-fibromyalgia 
(control) women
Logistic regression analyses were conducted to calculate de odds ratio (OR) and 95% confidence interval (95% CI)
COMT catechol‑O‑methyltransferase gene, GCH1 GTP cyclohydrolase 1 gene, OPRM1 opioid receptor μ1 gene, A Adenine, C Cytosine, G Guanine, T Thymine





(95% CI, lower to upper)
p value
rs841 (GCH1) AA/AG 72 (23.2) 37 (33.3) 1.66 (1.03–2.67) 0.04
GG 239 (76.8) 74 (66.7)
A 76 (12.2) 40 (18.0) 1.58 (1.04–2.40) 0.03
G 546 (87.8) 182 (82.0)
rs1799971 (OPRM1) AA/AG 137 (44.2) 64 (57.7) 1.72 (1.11–2.67) 0.02
GG 173 (55.8) 47 (42.3)
A 163 (26.3) 78 (35.1) 1.52 (1.09–2.11) 0.01
G 457 (73.7) 144 (64.9)
rs2097903 (COMT) AA 64 (21.2) 34 (30.9) 1.66 (1.02–2.71) 0.04
AT/TT 238 (78.8) 76 (69.1)
A 274 (45.4) 116 (52.7) 1.34 (0.99–1.83) 0.06
T 330 (54.6) 104 (47.3)
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the GCH1 gene were not associated with fibromyalgia 
susceptibility [9]. However, we found a significant asso-
ciation of the rs841 SNP and fibromyalgia susceptibil-
ity with 76.8% of the cases carrying the GG genotype 
vs. 66.7% of the controls. Interestingly, rs841 was the 
only SNP correlated to discomfort with a tender point 
examination in Korean patients [9]. Currently, no study 
in Caucasian population is available; therefore, future 
research testing associations of GCH1 gene SNPs, par-
ticularly the rs841, with fibromyalgia susceptibility in 
Caucasians is welcome.
A hypersensitive CNS also appears to have behavioural 
implications. An active lifestyle is associated with better 
health status in fibromyalgia [19–21]. However, impaired 
functioning of the anterior cingulate cortex and amyg-
dala, among other neural areas, may yield to processing 
harmless movements as painful [22]. The activity of these 
structures is modulated by μ-opioid receptor availabil-
ity, which is reduced in fibromyalgia [23]. In agreement 
with a study in Turkey [10], our findings suggest that the 
rs1799971 SNP confers fibromyalgia susceptibility, as 
most of the present patients’ sample were GG genotype 
(55.8%) and most of the controls were AA/AG (57.7%).
Most of the non-significant findings emerged in 
SNPs of sodium voltage-gated channel alpha subunit 9 
(SCN9A) and adrenoceptor alpha 1A (ADRA1A) genes. 
Genotype frequencies of a SCN9A SNP (rs6754031) 
were, however, significantly different between fibromyal-
gia and controls in Mexico [24]. ADRA1A gene activates 
mitogenic responses and regulates growth and prolif-
eration of many cells. In two subsamples (from Spain 
and Mexico), a previous study analysed associations of 
4 ADRA1A SNPs [25], showing that only rs1383914 was 
associated with an increased risk of fibromyalgia suscep-
tibility in the Spanish sample [25].
We did not include a replication sample; therefore, our 
findings must be interpreted with caution until they are 
corroborated or refuted in future studies conducted in 
independent samples. In order to prevent flares on pain, 
we collected mucosa cells using buccal swabs (i.e., a both 
low level of invasiveness and pain method), which on the 
other hand, precludes conducting a functional study (e.g., 
gene or protein expression). The unadjusted analyses 
for multiple comparisons are another limitation, which 
would yield to non-significant differences in the genotype 
frequencies of the SNPs. However, to conclude that there 
is no difference from a statistical point of view would be 
too stringent. Our findings may be biologically meaning-
ful and informative, and should be further investigated in 
other populations. Additionally, the unbalanced size of 
the study cases and controls limits our statistical power. 
We included, however, more people in the smaller group 
(cases, n = 112) than most of previous studies [26].
Conclusions
In conclusion, we identified associations of the rs841 
(GCH1 gene) and rs2097903 (COMT gene) SNPs with 
higher risk of fibromyalgia. We also confirmed that 
rs1799971 SNP (OPRM1 gene) seem to confer higher 
susceptibility to fibromyalgia. Further studies are needed 
to confirm or refute the present findings.
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